OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study

NCT00134160 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Cardiovascular Diseases

Interventions

DRUG: Olmesartan medoxomil
DRUG: Calcium channel blockers (amlodipine, azelnidipine)

Sponsor

OSCAR Study

Collaborators

[object Object]